123 related articles for article (PubMed ID: 38123492)
1. Clinical course of suspected familial and sporadic idiopathic pulmonary fibrosis: Data from the PROOF-Next registry.
Froidure A; Bondue B; Dahlqvist C; Guiot J; Gusbin N; Wirtz G; Brusselle G; Strens D; Slabbynck H; Wuyts WA
Respirology; 2024 Apr; 29(4):304-311. PubMed ID: 38123492
[TBL] [Abstract][Full Text] [Related]
2. Progressive Disease With Low Survival in Adult Patients With Pulmonary Fibrosis Carrying Surfactant-Related Gene Mutations: An Observational Study.
Klay D; Grutters JC; van der Vis JJ; Platenburg MGJP; Kelder JC; Tromp E; van Moorsel CHM
Chest; 2023 Apr; 163(4):870-880. PubMed ID: 36370864
[TBL] [Abstract][Full Text] [Related]
3. A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features.
Fernandez BA; Fox G; Bhatia R; Sala E; Noble B; Denic N; Fernandez D; Duguid N; Dohey A; Kamel F; Edwards L; Mahoney K; Stuckless S; Parfrey PS; Woods MO
Respir Res; 2012 Aug; 13(1):64. PubMed ID: 22853774
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry.
Wuyts WA; Dahlqvist C; Slabbynck H; Schlesser M; Gusbin N; Compere C; Maddens S; Lee YC; Kirchgaessler KU; Bartley K; Bondue B
Respir Res; 2019 Oct; 20(1):231. PubMed ID: 31651324
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone Therapy for Familial Pulmonary Fibrosis: A Real-Life Study.
Bennett D; Refini RM; Valentini ML; Fui A; Fossi A; Pieroni M; Mazzei MA; Rottoli P
Lung; 2019 Apr; 197(2):147-153. PubMed ID: 30758708
[TBL] [Abstract][Full Text] [Related]
6. The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis.
Copeland CR; Donnelly EF; Mehrad M; Ding G; Markin CR; Douglas K; Wu P; Cogan JD; Young LR; Bartholmai BJ; Martinez FJ; Flaherty KR; Loyd JE; Lancaster LH; Kropski JA; Blackwell TS; Salisbury ML
Ann Am Thorac Soc; 2022 Dec; 19(12):2003-2012. PubMed ID: 35877079
[No Abstract] [Full Text] [Related]
7. Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF).
Krauss E; Gehrken G; Drakopanagiotakis F; Tello S; Dartsch RC; Maurer O; Windhorst A; von der Beck D; Griese M; Seeger W; Guenther A
BMC Pulm Med; 2019 Jul; 19(1):130. PubMed ID: 31319833
[TBL] [Abstract][Full Text] [Related]
8. Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease.
Cutting CC; Bowman WS; Dao N; Pugashetti JV; Garcia CK; Oldham JM; Newton CA
Chest; 2021 May; 159(5):1913-1921. PubMed ID: 33484728
[TBL] [Abstract][Full Text] [Related]
9. Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns.
Bennett D; Mazzei MA; Squitieri NC; Bargagli E; Refini RM; Fossi A; Volterrani L; Rottoli P
Respir Med; 2017 May; 126():75-83. PubMed ID: 28427553
[TBL] [Abstract][Full Text] [Related]
10. Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry.
Behr J; Prasse A; Wirtz H; Koschel D; Pittrow D; Held M; Klotsche J; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Kahn N; Welte T; Neurohr C; Schwaiblmair M; Bahmer T; Oqueka T; Frankenberger M; Kreuter M
Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32381492
[TBL] [Abstract][Full Text] [Related]
11. Lung transplant in patients with familial pulmonary fibrosis.
Bennett D; Fossi A; Lanzarone N; Vita E; Luzzi L; Paladini P; Bargagli E; Rottoli P; Sestini P
J Bras Pneumol; 2020; 46(6):e20200032. PubMed ID: 32725047
[TBL] [Abstract][Full Text] [Related]
12. The Extent of Inflammatory Cell Infiltrate and Fibrosis in Lungs of Telomere- and Surfactant-Related Familial Pulmonary Fibrosis.
van Batenburg AA; van Oosterhout MFM; Knoppert SN; Kazemier KM; van der Vis JJ; Grutters JC; Goldschmeding R; van Moorsel CHM
Front Med (Lausanne); 2021; 8():736485. PubMed ID: 34631753
[TBL] [Abstract][Full Text] [Related]
13. Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.
Hunninghake GM; Quesada-Arias LD; Carmichael NE; Martinez Manzano JM; Poli De Frías S; Baumgartner MA; DiGianni L; Gampala-Sagar SN; Leone DA; Gulati S; El-Chemaly S; Goldberg HJ; Putman RK; Hatabu H; Raby BA; Rosas IO
Am J Respir Crit Care Med; 2020 May; 201(10):1240-1248. PubMed ID: 32011908
[No Abstract] [Full Text] [Related]
14. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Feng H; Zhao Y; Li Z; Kang J
Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic treatment response and prognostic predictors in patients with idiopathic pulmonary fibrosis and exposed to occupational dust.
Casillo V; Cerri S; Ciervo A; Stendardo M; Manzoli L; Flacco ME; Manno M; Bocchino M; Luppi F; Boschetto P
BMC Pulm Med; 2019 Sep; 19(1):170. PubMed ID: 31488107
[TBL] [Abstract][Full Text] [Related]
16. Comparisons of Prognosis between Surgically and Clinically Diagnosed Idiopathic Pulmonary Fibrosis Using Gap Model: A Korean National Cohort Study.
Lee SH; Kim SY; Kim DS; Kim YW; Chung MP; Uh ST; Park CS; Jeong SH; Park YB; Lee HL; Shin JW; Lee EJ; Lee JH; Jegal Y; Lee HK; Kim YH; Song JW; Park MS
Medicine (Baltimore); 2016 Mar; 95(11):e3105. PubMed ID: 26986154
[TBL] [Abstract][Full Text] [Related]
17. The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study.
Cameli P; Alonzi V; d'Alessandro M; Bergantini L; Pordon E; Guerrieri M; Refini RM; Sestini P; Bargagli E
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009520
[TBL] [Abstract][Full Text] [Related]
18. Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry.
Gao J; Kalafatis D; Carlson L; Pesonen IHA; Li CX; Wheelock Å; Magnusson JM; Sköld CM
Respir Res; 2021 Feb; 22(1):40. PubMed ID: 33546682
[TBL] [Abstract][Full Text] [Related]
19. Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry.
Salisbury ML; Conoscenti CS; Culver DA; Yow E; Neely ML; Bender S; Hartmann N; Palmer SM; Leonard TB;
Ann Am Thorac Soc; 2020 Nov; 17(11):1413-1423. PubMed ID: 32574517
[No Abstract] [Full Text] [Related]
20. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
